Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
13.84
-0.14 (-1.00%)
At close: May 22, 2026, 4:00 PM EDT
14.00
+0.16 (1.16%)
After-hours: May 22, 2026, 4:15 PM EDT

Cullinan Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-221.04-219.88-167.58-155.1109.2-67.49
Depreciation & Amortization
0.310.310.310.310.090.05
Stock-Based Compensation
34.2836.0437.8230.4427.9624.38
Other Adjustments
-4.77-6.31-15.47-9.58-275.093.17
Changes in Accounts Payable
-0.89-0.84-0.81-0.17-0.51-4.84
Changes in Accrued Expenses
8.978.032.910.058.534.56
Changes in Income Taxes Payable
----4.284.28-
Changes in Other Operating Activities
4.496.9-2.47-5.94-1.13-3.27
Operating Cash Flow
-178.64-175.75-145.3-134.28-126.66-43.43
Capital Expenditures
-0.01-0.05--0.21-1.13-
Sale of Property, Plant & Equipment
----0.09-
Purchases of Investments
-130.83-236.53-721.13-373.38-377.92-525.81
Proceeds from Sale of Investments
306.48416.57584.82409.4352.93192.04
Proceeds from Business Divestments
----275-
Investing Cash Flow
175.6179.99-136.3135.81248.98-333.78
Long-Term Debt Issued
---1.832.38-
Long-Term Debt Repaid
-----2.2-
Net Long-Term Debt Issued (Repaid)
---1.830.18-
Issuance of Common Stock
1.471.09270.6438.936.02270.55
Repurchase of Common Stock
---4.45--33.28-
Net Common Stock Issued (Repurchased)
1.471.09266.1938.93-27.26270.55
Other Financing Activities
----1.15-1.77
Financing Cash Flow
1.471.09266.1940.75-25.93268.78
Net Cash Flow
-1.575.33-15.43-57.7296.38-108.42
Free Cash Flow
-178.65-175.8-145.3-134.48-127.8-43.43
FCF Margin
------229.28%
Free Cash Flow Per Share
-3.50-2.98-2.70-2.82-2.74-1.01
Levered Free Cash Flow
-158.5-205.53-167.47-151.57121.53-69.06
Unlevered Free Cash Flow
-227.47-227.3-197.14-175.38114.52-71.44
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q